GAMMA Investing LLC Has $8.30 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

GAMMA Investing LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 7.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,838 shares of the healthcare conglomerate's stock after purchasing an additional 1,089 shares during the period. UnitedHealth Group accounts for approximately 0.6% of GAMMA Investing LLC's portfolio, making the stock its 22nd largest holding. GAMMA Investing LLC's holdings in UnitedHealth Group were worth $8,295,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the company. Sherbrooke Park Advisers LLC acquired a new position in UnitedHealth Group during the fourth quarter worth approximately $515,000. Full Sail Capital LLC increased its position in UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock worth $815,000 after purchasing an additional 33 shares during the last quarter. Soros Fund Management LLC purchased a new stake in UnitedHealth Group during the fourth quarter worth approximately $39,413,000. Silvercrest Asset Management Group LLC grew its stake in UnitedHealth Group by 47.8% during the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate's stock worth $19,625,000 after buying an additional 12,550 shares during the period. Finally, Novem Group purchased a new stake in UnitedHealth Group during the fourth quarter worth approximately $854,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UNH stock traded up $6.23 during trading hours on Friday, reaching $308.85. The stock had a trading volume of 13,584,804 shares, compared to its average volume of 7,404,577. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The firm has a 50-day simple moving average of $336.21 and a 200-day simple moving average of $453.97. The firm has a market capitalization of $280.17 billion, a PE ratio of 12.93, a price-to-earnings-growth ratio of 1.46 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the business earned $6.91 earnings per share. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.86%. The ex-dividend date was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.

Analysts Set New Price Targets

Several research firms have issued reports on UNH. Wells Fargo & Company reiterated an "overweight" rating on shares of UnitedHealth Group in a research note on Friday, June 6th. Argus downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. Deutsche Bank Aktiengesellschaft decreased their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research note on Wednesday, May 14th. JPMorgan Chase & Co. upped their target price on shares of UnitedHealth Group from $405.00 to $418.00 and gave the company an "overweight" rating in a research note on Friday, June 20th. Finally, Raymond James Financial downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $415.57.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,533 shares of the business's stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director now owns 6,033 shares of the company's stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director John H. Noseworthy purchased 300 shares of the business's stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the acquisition, the director now directly owns 6,063 shares in the company, valued at $1,892,626.08. This represents a 5.21% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.28% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.